Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma
<p>Statistics from DESeq2</p>
שמור ב:
| מחבר ראשי: | |
|---|---|
| מחברים אחרים: | , , , , , , , , , , , , , , , , , , , , , , |
| יצא לאור: |
2025
|
| נושאים: | |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
| _version_ | 1849927632436592640 |
|---|---|
| author | Alyssa C. Flint (16676029) |
| author2 | Dana K. Mitchell (16676032) Steven P. Angus (15084264) Abbi E. Smith (16676035) Waylan Bessler (16676038) Li Jiang (16676041) Henry Mang (15293185) Xiaohong Li (16676044) Qingbo Lu (16676047) Brooke Rodriguez (16676050) George E. Sandusky (16676053) Andi R. Masters (16676056) Chi Zhang (15084270) Pengtao Dang (16676059) Jenna Koenig (16676062) Gary L. Johnson (15081520) Weihua Shen (16676065) Jiangang Liu (15018711) Amit Aggarwal (16610489) Gregory P. Donoho (16676068) Melinda D. Willard (16676071) Shripad V. Bhagwat (16676074) D. Wade Clapp (16676077) Steven D. Rhodes (16676080) |
| author2_role | author author author author author author author author author author author author author author author author author author author author author author author |
| author_facet | Alyssa C. Flint (16676029) Dana K. Mitchell (16676032) Steven P. Angus (15084264) Abbi E. Smith (16676035) Waylan Bessler (16676038) Li Jiang (16676041) Henry Mang (15293185) Xiaohong Li (16676044) Qingbo Lu (16676047) Brooke Rodriguez (16676050) George E. Sandusky (16676053) Andi R. Masters (16676056) Chi Zhang (15084270) Pengtao Dang (16676059) Jenna Koenig (16676062) Gary L. Johnson (15081520) Weihua Shen (16676065) Jiangang Liu (15018711) Amit Aggarwal (16610489) Gregory P. Donoho (16676068) Melinda D. Willard (16676071) Shripad V. Bhagwat (16676074) D. Wade Clapp (16676077) Steven D. Rhodes (16676080) |
| author_role | author |
| dc.creator.none.fl_str_mv | Alyssa C. Flint (16676029) Dana K. Mitchell (16676032) Steven P. Angus (15084264) Abbi E. Smith (16676035) Waylan Bessler (16676038) Li Jiang (16676041) Henry Mang (15293185) Xiaohong Li (16676044) Qingbo Lu (16676047) Brooke Rodriguez (16676050) George E. Sandusky (16676053) Andi R. Masters (16676056) Chi Zhang (15084270) Pengtao Dang (16676059) Jenna Koenig (16676062) Gary L. Johnson (15081520) Weihua Shen (16676065) Jiangang Liu (15018711) Amit Aggarwal (16610489) Gregory P. Donoho (16676068) Melinda D. Willard (16676071) Shripad V. Bhagwat (16676074) D. Wade Clapp (16676077) Steven D. Rhodes (16676080) |
| dc.date.none.fl_str_mv | 2025-11-25T13:24:23Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30708760 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Table_S5_from_Combined_CDK4_6_and_ERK1_2_Inhibition_Enhances_Antitumor_Activity_in_NF1-Associated_Plexiform_Neurofibroma/30708760 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Cell Cycle CDKs and CDK inhibitors Chemotherapy Combination chemotherapy Gene Technologies High-throughput sequencing Preclinical Models Animal models of cancer Proteomics Rare Cancers Translational Research |
| dc.title.none.fl_str_mv | Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Statistics from DESeq2</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_7732ff6e312405125d2246fc1d7b7b7c |
| identifier_str_mv | 10.1158/1078-0432.30708760 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30708760 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform NeurofibromaAlyssa C. Flint (16676029)Dana K. Mitchell (16676032)Steven P. Angus (15084264)Abbi E. Smith (16676035)Waylan Bessler (16676038)Li Jiang (16676041)Henry Mang (15293185)Xiaohong Li (16676044)Qingbo Lu (16676047)Brooke Rodriguez (16676050)George E. Sandusky (16676053)Andi R. Masters (16676056)Chi Zhang (15084270)Pengtao Dang (16676059)Jenna Koenig (16676062)Gary L. Johnson (15081520)Weihua Shen (16676065)Jiangang Liu (15018711)Amit Aggarwal (16610489)Gregory P. Donoho (16676068)Melinda D. Willard (16676071)Shripad V. Bhagwat (16676074)D. Wade Clapp (16676077)Steven D. Rhodes (16676080)CancerMolecular and Cellular BiologyTherapeutic Research and DevelopmentMethods and TechnologyCell CycleCDKs and CDK inhibitorsChemotherapyCombination chemotherapyGene TechnologiesHigh-throughput sequencingPreclinical ModelsAnimal models of cancerProteomicsRare CancersTranslational Research<p>Statistics from DESeq2</p>2025-11-25T13:24:23ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30708760https://figshare.com/articles/dataset/Table_S5_from_Combined_CDK4_6_and_ERK1_2_Inhibition_Enhances_Antitumor_Activity_in_NF1-Associated_Plexiform_Neurofibroma/30708760CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307087602025-11-25T13:24:23Z |
| spellingShingle | Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma Alyssa C. Flint (16676029) Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Cell Cycle CDKs and CDK inhibitors Chemotherapy Combination chemotherapy Gene Technologies High-throughput sequencing Preclinical Models Animal models of cancer Proteomics Rare Cancers Translational Research |
| status_str | publishedVersion |
| title | Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma |
| title_full | Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma |
| title_fullStr | Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma |
| title_full_unstemmed | Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma |
| title_short | Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma |
| title_sort | Table S5 from Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma |
| topic | Cancer Molecular and Cellular Biology Therapeutic Research and Development Methods and Technology Cell Cycle CDKs and CDK inhibitors Chemotherapy Combination chemotherapy Gene Technologies High-throughput sequencing Preclinical Models Animal models of cancer Proteomics Rare Cancers Translational Research |